41.96

0.80% 0.3286

Livanova Plc (LIVN)

Overview News Price History Option Chain Financials Discussions Forecast

Livanova Plc stock is traded at $41.96, with a volume of 180.86K. It is up +0.80% in the last 24 hours and down -12.68% over the past month. UK-based LivaNova was born of a combination between Cyberonics in the us and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management and heart valve businesses. It derives roughly half of its revenue from the us market, another 21% from Europe, and the remainder from the rest of the world.

Previous Close:

$41.63

Open:

$42.23

24h Volume:

180.86K

Relative Volume:

0.35

Market Cap:

$2.29B

Revenue:

$1.24B

Net Income/Loss:

$23.68M

P/E Ratio:

99.90

EPS:

0.42

Net Cash Flow:

$108.67M

1W Performance:

-15.22%

1M Performance:

-12.68%

6M Performance:

-15.36%

1Y Performance:

-24.03%

1-Day Range:

$41.06

$42.32

1-Week Range:

$40.37

$47.48

52-Week Range:

$40.37

$64.47

Livanova Plc Stock (LIVN) Company Profile

Name

Livanova Plc

Sector

Healthcare (1188)

Industry

Medical Devices (159)

Phone

4402033250662

Address

20 EASTBOURNE TERRACE, LONDON

Employee

2,900

Twitter

Next Earnings Date

2024-10-30

Latest SEC Filings

LIVN's Discussions on Twitter

Compare LIVN with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LIVN Livanova Plc	41.87	2.29B	1.24B	23.68M	108.67M	0.42
ABT Abbott Laboratories	140.25	241.69B	41.95B	13.40B	6.35B	7.65
BSX Boston Scientific Corp	105.08	153.75B	16.75B	1.85B	2.37B	1.25
SYK Stryker Corp	395.70	150.24B	22.60B	2.99B	3.49B	7.76
MDT Medtronic Plc	94.30	120.56B	33.20B	4.26B	5.47B	3.29
EW Edwards Lifesciences Corp	72.44	42.42B	5.72B	4.17B	490.10M	6.97

Livanova Plc Stock (LIVN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-26-25	Downgrade	Wolfe Research	Outperform → Peer Perform
Oct-04-24	Initiated	Goldman	Buy
Sep-17-24	Upgrade	Robert W. Baird	Neutral → Outperform
Mar-20-24	Reiterated	Needham	Buy
Feb-20-24	Upgrade	Mizuho	Neutral → Buy
Sep-06-23	Initiated	HSBC Securities	Hold
Jul-19-23	Initiated	Robert W. Baird	Neutral
Apr-14-23	Initiated	Mizuho	Neutral
Dec-21-22	Initiated	Barclays	Equal Weight
Apr-06-22	Initiated	Wolfe Research	Outperform
Feb-24-22	Upgrade	UBS	Neutral → Buy
Dec-03-21	Initiated	Goldman	Buy
Aug-20-21	Reiterated	Needham	Buy
Jul-20-21	Upgrade	Needham	Hold → Buy
Mar-03-21	Downgrade	Berenberg	Buy → Hold
Jan-05-21	Downgrade	Needham	Buy → Hold
Sep-02-20	Initiated	Robert W. Baird	Outperform
Jun-26-20	Reiterated	Needham	Buy
Oct-30-19	Reiterated	Needham	Buy
Feb-28-19	Reiterated	Needham	Buy
Nov-28-18	Initiated	UBS	Neutral
Aug-02-18	Reiterated	Needham	Buy
Jun-08-18	Initiated	Stifel	Buy
May-31-18	Reiterated	Needham	Buy
Feb-28-18	Reiterated	Needham	Buy

View All

Livanova Plc Stock (LIVN) Latest News

Mar 01, 2025

LivaNova (NASDAQ:LIVN) Given New $60.00 Price Target at Mizuho - MarketBeat

Mar 01, 2025

Needham & Company LLC Has Lowered Expectations for LivaNova (NASDAQ:LIVN) Stock Price - MarketBeat

Mar 01, 2025

Stifel Nicolaus Lowers LivaNova (NASDAQ:LIVN) Price Target to $60.00 - MarketBeat

Feb 28, 2025

LivaNova (NASDAQ:LIVN) Issues FY25 Earnings Guidance - MarketBeat

Feb 28, 2025

LivaNova (NASDAQ:LIVN) Stock Rating Lowered by Wolfe Research - MarketBeat

Feb 28, 2025

How To Trade (LIVN) - Stock Traders Daily

Feb 28, 2025

Decoding LivaNova PLC (LIVN): A Strategic SWOT Insight - GuruFocus.com

Feb 28, 2025

LivaNova’s Roller Coaster Ride: A Glimmer Amidst Investor Skepticism - MotoPaddock

Feb 28, 2025

LivaNova PLC Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year - Simply Wall St

Feb 28, 2025

LivaNova PLC Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - Yahoo Finance

Feb 28, 2025

LivaNova (NASDAQ:LIVN) Rating Lowered to "Buy" at StockNews.com - MarketBeat

Feb 28, 2025

Feb 27, 2025

LivaNova fourth-quarter revenue increases 3.8% to USD 321.8M - Medical Buyer

Feb 27, 2025

LivaNova PLC Reports Strong Growth Amid Challenges - TipRanks

Feb 27, 2025

LivaNova (NASDAQ:LIVN) Trading Up 4%What's Next? - MarketBeat

Feb 27, 2025

Feb 26, 2025

Wolfe Research Downgrades LivaNova to Peer Perform From Outperform -February 26, 2025 at 08:20 am EST - Marketscreener.com

Feb 26, 2025

LivaNova PLC (NASDAQ:LIVN) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 26, 2025

Mizuho cuts Livanova stock target to $60, maintains Outperform By Investing.com - Investing.com UK

Feb 26, 2025

LivaNova Full Year 2024 Earnings: EPS Beats Expectations - Yahoo Finance

Feb 26, 2025

Livanova (LIVN) PT Lowered to $60 at Mizuho - StreetInsider.com

Feb 26, 2025

LivaNova Plc to Host Earnings Call - ACCESS Newswire

Feb 26, 2025

LivaNova downgraded to Peer Perform from Outperform at Wolfe Research - TipRanks

Feb 26, 2025

Livanova stock rating downgraded at Wolfe Research By Investing.com - Investing.com South Africa

Feb 26, 2025